{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:21:15Z","timestamp":1789759275446,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,28]]},"DOI":"10.7759\/cureus.72576","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:32:45Z","timestamp":1730161965000},"source":"Crossref","is-referenced-by-count":3,"title":["Screening For Occult Heart Failure in Type 2 Diabetes Mellitus Using NT-proBNP: Real-World Evidence From a Tertiary Care Center in India"],"prefix":"10.7759","author":[{"given":"Ameya","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Hajirnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandani","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit P","family":"Pakhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitinkumar","family":"Abdagire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Khatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi P","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al.. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019, 157:107843. 10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0014","article-title":"Heart Failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui R","year":"2022","unstructured":"Pop-Busui R, Januzzi JL, Bruemmer D, et al.. Heart Failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association. Diabetes Care. 2022, 45:1670-90. 10.2337\/dci22-0014","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S010","article-title":"Cardiovascular disease and risk management: standards of care in diabetes-2024","volume":"47","year":"2024","unstructured":"Cardiovascular disease and risk management. standards of care in diabetes-2024. Diabetes Care. 2024, 47:S179-218. 10.2337\/dc24-S010","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.071233","article-title":"Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine","volume":"92","author":"Weber M","year":"2006","unstructured":"Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006, 92:843-9. 10.1136\/hrt.2005.071233","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.015","article-title":"Amino-terminal pro-B-type natriuretic peptide testing in patients with diabetes mellitus and with systemic hypertension","volume":"101","author":"Hildebrandt P","year":"2008","unstructured":"Hildebrandt P, Richards AM. Amino-terminal pro-B-type natriuretic peptide testing in patients with diabetes mellitus and with systemic hypertension. Am J Cardiol. 2008, 101:21-4. 10.1016\/j.amjcard.2007.11.015","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110165","article-title":"Diabetes and NT-proBNP: partners in crime","volume":"194","author":"Bayes-Genis A","year":"2022","unstructured":"Bayes-Genis A. Diabetes and NT-proBNP: partners in crime. Diabetes Res Clin Pract. 2022, 194:110165. 10.1016\/j.diabres.2022.110165","journal-title":"Diabetes Res Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies MJ","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, et al.. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022, 65:1925-66. 10.1007\/s00125-022-05787-2","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab670","article-title":"Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021, 42:4901. 10.1093\/eurheartj\/ehab670","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.87.1.152","article-title":"Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia","volume":"87","author":"McKeigue PM","year":"1993","unstructured":"McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation. 1993, 87:152-61. 10.1161\/01.cir.87.1.152","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2023.10.003","article-title":"Prevalence of cardiac abnormalities and heart failure in unselected out-patients with type 2 diabetes mellitus and associated clinical factors: real-world evidence from an Indian registry","volume":"75","author":"Rajput R","year":"2023","unstructured":"Rajput R, Mohan JC, Sawhney JP, et al.. Prevalence of cardiac abnormalities and heart failure in unselected out-patients with type 2 diabetes mellitus and associated clinical factors: real-world evidence from an Indian registry. Indian Heart J. 2023, 75:436-42. 10.1016\/j.ihj.2023.10.003","journal-title":"Indian Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2017.11.015","article-title":"Management protocols for chronic heart failure in India","volume":"70","author":"Mishra S","year":"2018","unstructured":"Mishra S, Mohan JC, Nair T, et al.. Management protocols for chronic heart failure in India. Indian Heart J. 2018, 70:105-27. 10.1016\/j.ihj.2017.11.015","journal-title":"Indian Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial","volume":"62","author":"Huelsmann M","year":"2013","unstructured":"Huelsmann M, Neuhold S, Resl M, et al.. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial. J Am Coll Cardiol. 2013, 62:1365-72. 10.1016\/j.jacc.2013.05.069","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108410","article-title":"NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension","volume":"37","author":"Ceriello A","year":"2023","unstructured":"Ceriello A, Lalic N, Montanya E, Valensi P, Khunti K, Hummel M, Schnell O. NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension. J Diabetes Complications. 2023, 37:108410. 10.1016\/j.jdiacomp.2023.108410","journal-title":"J Diabetes Complications"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_225_20","article-title":"RSSDI-ESI Clinical Practice Recommendations for the management of type 2 diabetes mellitus 2020","volume":"24","author":"Chawla R","year":"2020","unstructured":"Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S. RSSDI-ESI Clinical Practice Recommendations for the management of type 2 diabetes mellitus 2020. Indian J Endocrinol Metab. 2020, 24:1-122. 10.4103\/ijem.IJEM_225_20","journal-title":"Indian J Endocrinol Metab"},{"key":"ref15","article-title":"Diabetes mellitus and heart failure: a consensus statement","volume":"40","author":"Saboo B","year":"2021","unstructured":"Saboo B, Agarwal S, Singh AK, et al.. Diabetes mellitus and heart failure: a consensus statement. Int J Diabetes Dev Ctries. 2021, 40:S1-41.","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154910","article-title":"Heart failure in diabetes","volume":"125","author":"Jankauskas SS","year":"2021","unstructured":"Jankauskas SS, Kansakar U, Varzideh F, et al.. Heart failure in diabetes. Metabolism. 2021, 125:154910. 10.1016\/j.metabol.2021.154910","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus","volume":"138","author":"McAllister DA","year":"2018","unstructured":"McAllister DA, Read SH, Kerssens J, et al.. Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus. Circulation. 2018, 138:2774-86. 10.1161\/CIRCULATIONAHA.118.034986","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz835","article-title":"Sex differences in heart failure","volume":"40","author":"Lam CS","year":"2019","unstructured":"Lam CS, Arnott C, Beale AL, et al.. Sex differences in heart failure. Eur Heart J. 2019, 40:3859-3868c. 10.1093\/eurheartj\/ehz835","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031912","article-title":"Cigarette smoking and incident heart failure: insights from the Jackson Heart Study","volume":"137","author":"Kamimura D","year":"2018","unstructured":"Kamimura D, Cain LR, Mentz RJ, et al.. Cigarette smoking and incident heart failure: insights from the Jackson Heart Study. Circulation. 2018, 137:2572-82. 10.1161\/CIRCULATIONAHA.117.031912","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-09987-z","article-title":"Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers","volume":"27","author":"Triposkiadis F","year":"2022","unstructured":"Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D. Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers. Heart Fail Rev. 2022, 27:337-44. 10.1007\/s10741-020-09987-z","journal-title":"Heart Fail Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2021.12.011","article-title":"Hypertension and heart failure: prevention, targets, and treatment","volume":"40","author":"Di Palo KE","year":"2022","unstructured":"Di Palo KE, Barone NJ. Hypertension and heart failure: prevention, targets, and treatment. Cardiol Clin. 2022, 40:237-44. 10.1016\/j.ccl.2021.12.011","journal-title":"Cardiol Clin"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2019.06.007","article-title":"Hypertension and heart failure","volume":"15","author":"Slivnick J","year":"2019","unstructured":"Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019, 15:531-41. 10.1016\/j.hfc.2019.06.007","journal-title":"Heart Fail Clin"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2023.05.003","article-title":"Heart failure and obesity: the latest pandemic","volume":"78","author":"Aryee EK","year":"2023","unstructured":"Aryee EK, Ozkan B, Ndumele CE. Heart failure and obesity: the latest pandemic. Prog Cardiovasc Dis. 2023, 78:43-8. 10.1016\/j.pcad.2023.05.003","journal-title":"Prog Cardiovasc Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-314770","article-title":"Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis","volume":"106","author":"Mahajan R","year":"2020","unstructured":"Mahajan R, Stokes M, Elliott A, et al.. Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis. Heart. 2020, 106:58-68. 10.1136\/heartjnl-2019-314770","journal-title":"Heart"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2681-3","article-title":"The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes","volume":"55","author":"Lind M","year":"2012","unstructured":"Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbj\u00f6rnsdottir S. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia. 2012, 55:2946-53. 10.1007\/s00125-012-2681-3","journal-title":"Diabetologia"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S006","article-title":"Glycemic targets: standards of medical care in diabetes-2022","volume":"45","year":"2022","unstructured":"Glycemic targets. standards of medical care in diabetes-2022. Diabetes Care. 2022, 45:S83-96. 10.2337\/dc22-S006","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.028","article-title":"Albuminuria and heart\u00a0failure: JACC state-of-the-art review","volume":"81","author":"Khan MS","year":"2023","unstructured":"Khan MS, Shahid I, Anker SD, et al.. Albuminuria and heart\u00a0failure: JACC state-of-the-art review. J Am Coll Cardiol. 2023, 81:270-82. 10.1016\/j.jacc.2022.10.028","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100398","article-title":"Lipoprotein(a), family history of cardiovascular disease, and incidence of heart failure","volume":"64","author":"Wang HP","year":"2023","unstructured":"Wang HP, Zhang N, Liu YJ, Xia TL, Chen GC, Yang J, Li FR. Lipoprotein(a), family history of cardiovascular disease, and incidence of heart failure. J Lipid Res. 2023, 64:100398. 10.1016\/j.jlr.2023.100398","journal-title":"J Lipid Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46911","article-title":"Association of pioglitazone with major adverse cardiovascular events, all-cause mortality, and heart failure hospitalizations: a systematic review","volume":"15","author":"Sheikh IM","year":"2023","unstructured":"Sheikh IM, Hassan OA, Adam SM, et al.. Association of pioglitazone with major adverse cardiovascular events, all-cause mortality, and heart failure hospitalizations: a systematic review. Cureus. 2023, 15:e46911. 10.7759\/cureus.46911","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32861-5","article-title":"Examining chronic disease onset across varying age groups of Indian adults using competing risk analysis","volume":"13","author":"Rashmi R","year":"2023","unstructured":"Rashmi R, Mohanty SK. Examining chronic disease onset across varying age groups of Indian adults using competing risk analysis. Sci Rep. 2023, 13:5848. 10.1038\/s41598-023-32861-5","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/311627-screening-for-occult-heart-failure-in-type-2-diabetes-mellitus-using-nt-probnp-real-world-evidence-from-a-tertiary-care-center-in-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:32:48Z","timestamp":1730161968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/311627-screening-for-occult-heart-failure-in-type-2-diabetes-mellitus-using-nt-probnp-real-world-evidence-from-a-tertiary-care-center-in-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.72576","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}